What it’s for
- Increasing EPA and DHA intake
Fish-oil products supplying the omega-3 fatty acids EPA and DHA.
Purpose, evidence and practical considerations.
Benefits depend on the indication, dose and formulation. The STRENGTH trial did not find fewer major cardiovascular events with its high-dose EPA/DHA formula; prescription EPA-only results should not be transferred to ordinary fish oil.
Confidence: strong
Fish oil can cause gastrointestinal symptoms and fishy aftertaste. Higher-dose omega-3 therapy is associated with increased atrial-fibrillation risk in trials; bleeding risk and medicine interactions should be reviewed, especially around procedures or anticoagulation.
EPA and DHA are long-chain omega-3 fatty acids incorporated into cell membranes and lipid signaling pathways. At prescription-level doses they lower triglycerides, but cardiovascular outcomes depend on the exact formulation and population.
Regulatory status: supplement (OTC fish oil) / nutrition (oily fish) / prescription medication (separate EPA+DHA and EPA-only drugs)
How people use it, with their schedules, context and original sources.
800 mg · Daily · 5:35 am with breakfast
depending on current cycle · with breakfast
brain function; possible extra benefit for women
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
daily
Brand variants reported in public protocols. Private entries are excluded, and inclusion is not an endorsement.
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.
daily in the January 2024 list
~2 g (about 1 g + about 1 g) · Daily · with breakfast and after dinner
cut from 4 g because her omega-3 index was 'just so high'; happy at 10–12%
with first meal around 2–3 p.m.